Article
The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from Taiwan.
Thoracic cancer - 1 May 2022
Cheng Wen-Chien, Shen Yi-Cheng, Chien Chun-Ru, Liao Wei-Chih, Chen Chia-Hung, Hsia Te-Chun, Tu Chih-Yeh, Chen Hung-Jen
Abstract excerpt
BACKGROUND: The treatment options for epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR-tyrosine kinase inhibitors (TKIs), stereotactic radiosurgery (SRS), whole-brain radiotherapy, brain surgery, and antiangiogenesis therapy. As treatment options evolve, redefining optimal treatment strategies to improve survival are crucial. METHODS: A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
